Literature DB >> 27401572

Nonprescription Antimicrobial Use in a Primary Care Population in the United States.

Roger Zoorob1, Larissa Grigoryan2, Susan Nash1, Barbara W Trautner3.   

Abstract

Community antimicrobial resistance rates are high in communities with frequent use of nonprescription antibiotics. Studies addressing nonprescription antibiotic use in the United States have been restricted to Latin American immigrants. We estimated the prevalence of nonprescription antibiotic use in the previous 12 months as well as intended use (intention to use antibiotics without a prescription) and storage of antibiotics and examined patient characteristics associated with nonprescription use in a random sample of adults. We selected private and public primary care clinics that serve ethnically and socioeconomically diverse patients. Within the clinics, we used race/ethnicity-stratified systematic random sampling to choose a random sample of primary care patients. We used a self-administered standardized questionnaire on antibiotic use. Multivariate regression analysis was used to identify independent predictors of nonprescription use. The response rate was 94%. Of 400 respondents, 20 (5%) reported nonprescription use of systemic antibiotics in the last 12 months, 102 (25.4%) reported intended use, and 57 (14.2%) stored antibiotics at home. These rates were similar across race/ethnicity groups. Sources of antibiotics used without prescriptions or stored for future use were stores or pharmacies in the United States, "leftover" antibiotics from previous prescriptions, antibiotics obtained abroad, or antibiotics obtained from a relative or friend. Respiratory symptoms were common reasons for the use of nonprescription antibiotics. In multivariate analyses, public clinic patients, those with less education, and younger patients were more likely to endorse intended use. The problem of nonprescription use is not confined to Latino communities. Community antimicrobial stewardship must include a focus on nonprescription antibiotics.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27401572      PMCID: PMC4997852          DOI: 10.1128/AAC.00528-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  Antibiotic use for the treatment of upper respiratory infections in a diverse community.

Authors:  M D McKee; L Mills; A G Mainous
Journal:  J Fam Pract       Date:  1999-12       Impact factor: 0.493

2.  Reversible "Faconi syndrome" caused by degraded tetracycline.

Authors:  G W FRIMPTER; A E TIMPANELLI; H S EISENMENGER WJ STEIN; L I EHRLICH
Journal:  JAMA       Date:  1963-04-13       Impact factor: 56.272

3.  The WHO policy package to combat antimicrobial resistance.

Authors:  Emily Leung; Diana E Weil; Mario Raviglione; Hiroki Nakatani
Journal:  Bull World Health Organ       Date:  2011-05-01       Impact factor: 9.408

Review 4.  Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries.

Authors:  Benedikt Huttner; Herman Goossens; Theo Verheij; Stephan Harbarth
Journal:  Lancet Infect Dis       Date:  2010-01       Impact factor: 25.071

5.  Outpatient antibiotic use in the United States: time to "get smarter".

Authors:  Benedikt Huttner; Matthew Samore
Journal:  Clin Infect Dis       Date:  2011-10       Impact factor: 9.079

6.  Oral antibiotic use without consulting a physician: a survey of ED patients.

Authors:  P B Richman; G Garra; B Eskin; A H Nashed; R Cody
Journal:  Am J Emerg Med       Date:  2001-01       Impact factor: 2.469

Review 7.  Human use of antimicrobial agents.

Authors:  P Zarb; H Goossens
Journal:  Rev Sci Tech       Date:  2012-04       Impact factor: 1.181

Review 8.  Antimicrobial resistance determinants and future control.

Authors:  Stephan Harbarth; Matthew H Samore
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

9.  Self-medication with antimicrobial drugs in Europe.

Authors:  Larissa Grigoryan; Flora M Haaijer-Ruskamp; Johannes G M Burgerhof; Reli Mechtler; Reginald Deschepper; Arjana Tambic-Andrasevic; Retnosari Andrajati; Dominique L Monnet; Robert Cunney; Antonella Di Matteo; Hana Edelsein; Rolanda Valinteliene; Alaa Alkerwi; Elizabeth Scicluna; Powel Grzesiowski; Ana-Claudia Bara; Thomas Tesar; Milan Cizman; Jose Campos; Cecilia Stålsby Lundborg; Joan Birkin
Journal:  Emerg Infect Dis       Date:  2006-03       Impact factor: 6.883

10.  "Get smart Colorado": impact of a mass media campaign to improve community antibiotic use.

Authors:  Ralph Gonzales; Kitty K Corbett; Shale Wong; Judith E Glazner; Ann Deas; Bonnie Leeman-Castillo; Judith H Maselli; Ann Sebert-Kuhlmann; Robert S Wigton; Estevan Flores; Karen Kafadar
Journal:  Med Care       Date:  2008-06       Impact factor: 2.983

View more
  17 in total

1.  Skin and Soft Tissue Infection in People Living With Human Immunodeficiency Virus in a Large, Urban, Public Healthcare System in Houston, Texas, 2009-2014.

Authors:  Vagish Hemmige; Cesar A Arias; Siavash Pasalar; Thomas P Giordano
Journal:  Clin Infect Dis       Date:  2020-04-15       Impact factor: 9.079

2.  Socioeconomic Inequality in Self-Medication in Iran: Cross-Sectional Analyses at the National and Subnational Levels.

Authors:  Satar Rezaei; Mohammad Hajizadeh; Sina Ahmadi; Mohammad Ebrahimi; Behzad Karami Matin
Journal:  Clinicoecon Outcomes Res       Date:  2020-07-31

Review 3.  The General Population's Inappropriate Behaviors and Misunderstanding of Antibiotic Use in China: A Systematic Review and Meta-Analysis.

Authors:  Lixia Duan; Chenxi Liu; Dan Wang
Journal:  Antibiotics (Basel)       Date:  2021-04-26

4.  Awareness about antibiotic resistance in a self-medication user group from Eastern Romania: a pilot study.

Authors:  Gabi Topor; Ionela-Alina Grosu; Cristina Mihaela Ghiciuc; Aurel Lulu Strat; Cătălina Elena Lupuşoru
Journal:  PeerJ       Date:  2017-09-12       Impact factor: 2.984

5.  Antibiotic restriction policy paradoxically increased private drug consumptions outside Taiwan's National Health Insurance.

Authors:  Shu-Chen Kuo; Shu-Man Shih; Li-Yun Hsieh; Tsai-Ling Yang Lauderdale; Yee-Chun Chen; Chao A Hsiung; Shan-Chwen Chang
Journal:  J Antimicrob Chemother       Date:  2017-05-01       Impact factor: 5.790

6.  Approaches to drug therapy for COPD in Russia: a proposed therapeutic algorithm.

Authors:  Kirill A Zykov; Svetlana I Ovcharenko
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-04-11

7.  Keeping Antibiotics at Home Promotes Self-Medication with Antibiotics among Chinese University Students.

Authors:  Xiaomin Wang; Leesa Lin; Ziming Xuan; Lu Li; Xudong Zhou
Journal:  Int J Environ Res Public Health       Date:  2018-04-05       Impact factor: 3.390

8.  Public knowledge and perception about antimicrobials and antimicrobial resistance in Japan: A national questionnaire survey in 2017.

Authors:  Kazuhiro Kamata; Yasuharu Tokuda; Yoshiaki Gu; Norio Ohmagari; Katsunori Yanagihara
Journal:  PLoS One       Date:  2018-11-05       Impact factor: 3.240

Review 9.  Control of Antimicrobial Resistance Requires an Ethical Approach.

Authors:  Ben Parsonage; Philip K Hagglund; Lloyd Keogh; Nick Wheelhouse; Richard E Brown; Stephanie J Dancer
Journal:  Front Microbiol       Date:  2017-11-02       Impact factor: 5.640

10.  Racial/Ethnic Disparities in Antimicrobial Drug Use, United States, 2014-2015.

Authors:  Scott W Olesen; Yonatan H Grad
Journal:  Emerg Infect Dis       Date:  2018-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.